Do Some Randomized Controlled Trials Stack the Deck?

Patients in the control arm of cancer drug trials who progress are frequently not crossed over to the proven active therapy, leading to suboptimal care and problematic science, critics say.


Medscape Medical News

source https://www.medscape.com/viewarticle/994863?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?